
News|Articles|April 2, 2003
- Pharmaceutical Technology-04-02-2003
- Volume 27
- Issue 4
Overhauling Compliance and GMPs
Author(s)Jill Wechsler
FDA's newly launched risk-based approach to GMP regulation spurs signficant changes in the agency's approach to inspection processes, postapproval changes, and 21 CFR Part 11 enforcement.
Advertisement
Articles in this issue
almost 23 years ago
Outsourcing Outlookalmost 23 years ago
April 2003almost 23 years ago
Identification of Out-of-Trend Stability ResultsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
2
Women in STEM: Early Phase Drug Development
3
Rare Disease Treatments: Navigating the Economics of Global Innovation
4
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
5




